Nul raises €840K Seed round
16 February 2026· London, United Kingdom· health, telehealth, ai, b2b, pure_software
The funding will support Nul's full commercial launch in the UK, expansion of its clinical and product teams, scaling of customer acquisition, and preparation for future international growth, including entry into the US market.
“Telehealth and online pharmacy platforms have transformed categories like weight loss and mental health, yet alcohol has been left behind despite the scale of the problem. Nul is about making evidence-based treatment accessible, discreet and compatible with real life.”
Investors
Leaddmg ventures
Also participating
B&Y Venture Partners
About Nul
Stage
Seed
Headquarters
London, United Kingdom
Founded
2024
Team Size
6–20
Sectors
healthtelehealthaib2bpure_software